Changes of ghrelin and brain natriuretic peptide levels in systemic vascular resistance after cardiopulmonary bypass

Journal of Physiology and Biochemistry

Volumn 64, Issue 3, 2008, Pages 221-230

  Rahman, A ^a   Aydin, S ^a   Bayar, M K ^a   Sahin, I ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Brain natriuretic peptide; Cardiopulmonary bypass; Ghrelin; Systemic vascular resistance

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; GHRELIN;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART INDEX; HEMODYNAMIC MONITORING; HUMAN; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SYSTEMIC VASCULAR RESISTANCE;

EID: 59849095816     PISSN: 11387548     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03178845     Document Type: Article

References (33)

1. Avidan, M.S., Meehan, N., Ponte, J., El-Gamel, A., Sherwood, R.A. (2001): Changes in brain natriuretic peptide concentrations following open cardiac surgery with cardioplegic cardiac arrest. Clin Chim Acta, 303, 127-132.
2. Aydin, S. (2007): Discovery of ghrelin hormone, its researches and its clinical applications. Turkish J Biochem, 32, 76-89.
3. Broglio, F., Gottero, C., Prodam, F., Gauna, C., Muccioli, G., Papotti, M., Abribat, T., Van Der Lely, A.J., Ghigo, E. (2004): Non-acylated ghrelin counteracts the metabolic but not the endocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab, 89, 3062-3065.
4. Cao, J.M., Ong, H., Chen, C. (2006): Effects of ghrelin and synthetic GH secretagogues on the cardiovascular system. Trends Endocrinol Metab, 17, 13-18.
5. Christakis, G.T., Fremes, S.E., Koch, JP, Harwood S, Juhasz S, Sharpe E, Deemar KA, Hamilton C, Chen E, Rao V. (1994): Determinants of low systemic vascular resistance during cardiopulmonary bypass. Ann Thorac Surg, 58, 1040-1049.
6. Gröschl, M., Uhr, M., Kraus, T. (2004): Evaluation of the comparability of commercial ghrelin assays. Clin Chem, 50, 457-458.
7. Hosada, H., Doi, K., Nagaya, N., (2004): Optimum collection and storage conditions for ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to deacyl ghrelin in blood samples. Clin Chem, 50, 1077-1080.
8. Iglesias, M.J., Piñeiro, R., Blanco, M., Gallego, R., Diéguez, C., Gualillo, O., González-Juanatey, J.R., Lago, F. (2004): Growth hormone-releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovasc Res, 62, 481-488.
9. Kasimay, O., Iseri, S.O., Barlas, A., Bangir, D., Yegen, C., Arbak, S., Yegen, B.C. (2006): Ghrelin ameliorates pancreaticobiliary inflammation and associated remote organ injury in rats. Hepatol Res, 36, 11-19.
10. Kleinz, M.J., Maguire, J.J., Skepper, J.N., (2006): Functional and immunocytochemical evidence for a role ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man. Cardiovasc Res, 69, 227-235.
11. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., Kangawa, K. (1999): Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 402, 656-660.
12. Kojima, M., Kangawa, K. (2005): Ghrelin: structure and function. Physiol Rev, 85, 495-522.
13. Lin, Y., Matsumura, K., Fukuhara, M., Kagiyama, S., Fujii, K., Iida, M. (2004): Ghrelin acts at the nucleus of the solitary tract to decrease arterial pressure in rats. Hypertension, 43, 977-982.
14. Louagie, Y.A.G., Jamart, J., Gonzales, M., (2004): Continues cold cardioplegia improves myocardial protection: a prospective randomized study. Ann Thorac Surg, 77, 664-671.
15. Mair, P., Mair, J., Bleir, J., (1997): Augmented release of brain natriuretic peptide during reperfusion of the human heart after cardioplegic cardiac arrest. Clin Chim Acta, 261, 57-68.
16. Maisel, A.S., Krishnaswamy, P., Nowak, R.M., (2002): Breathing Not Properly Multinational Study Investigators. Rapid measurement of the B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med, 347, 161-167.
17. Morimoto, K., Mori, T., Ishiguro, S., (1998): Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgery. Surg Today, 28, 23-29.
18. Morris, D.C., Clements, S.D.Jr., Bailey, J.M. (2004): Management of the patient after cardiac surgery. In: "The Heart" (Fuster, V., Alexander, R.W. and O'Rourke, R.A., eds.). McGraw Hill, New York, pp. 1509-1516.
19. Nagaya, N., Kojima, M., Uematsu, M. (2001b): Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol, 280, R1483-R1487.
20. Nagaya, N., Miyatake, K., Uematsu, M., Oya, H., Shimizu, W., Hosoda, H., Kojima, M., Nakanishi, N., Mori, H., Kangawa, K. (2001a): Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. J Clin Endocrinol Metab, 86, 5854-5859.
21. Nakamura, K., Ueno, T., Yamamoto, H., (2005): Relationship between cerebral injury and inflammatory responses in patients undergoing cardiac surgery with cardiopulmonary bypass. Cytokine, 29, 95-104.
22. Ohata, T., Sawa, Y., Kadoba, K., Kagisaki, K., Suzuki, K., Matsuda, H. (2000): Role of nitric oxide in atemparature dependent regulation of systemic vascular resistance in cardiopulmonary bypass. Eur J Cardiothorac Surg, 18, 342-347.
23. Palazzuoli, A., Carrera, A., Calabria, P., (2004): Brain natriuretic peptide levels during cardiac reperfusion: comparison between percutaneous coronary angioplasty and aorto-coronaric bypass. Clin Chim Acta, 342, 87-92.
24. Pemberton, C.J., Tokola, H., Bagi, Z. (2004): Ghrelin induces vasoconstriction in the rat coronary vasculature without altering without altering cardiac peptide secretion. Am J Physiol Heart Circ Physiol, 287, H1522-H1529.
25. Protter, A.A., Wallace, A.M., Ferraris, V.A., Weishaar, R.E. (1996): Relaxant effect of human brain natriuretic peptide on human artery and vein tissue. Am J Hypertens, 9, 432-436.
26. Rastan, A.J., Bittner, H.B., Gummert, J.F., (2005): On-pump beating heart versus off-pump coronary artery bypass surgery-evidence of pump-induced myocardial injury. Eur J Cardiothorac Surg, 27, 1057-1064.
27. Sehirli, O., Sener, E., Sener, G., (2008): Ghrelin improves burn-induced multiple organ injury by depressing neutrophil infiltration and the release of pro-inflammatory cytokines. Peptides, 29, 1231-1240.
28. Shimizu, Y., Nagaya, N., Teranishi, Y., Imazu, M., Yamamoto, H., Shokawa, T., Kangawa, K., Kohno, N., Yoshizumi, M. (2003): Ghrelin improves endothelial dysfunction through growth hormone-independent mechanism in rats. Biochem Biophys Res Commun, 310, 830-835.
29. Stein, B.C., Levin, R.I. (1998): Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am Heart J, 135, 914-923.
30. Thomson, N.M., Gill, D.A., Davies, R., Loveridge, N., Houston, P.A., Robinson, I.C., Wells, T. (2004): Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of type 1a growth hormone secretagogue receptor. Endocrinology, 145, 234-242.
31. Van der Zander, K., Houben, A.J., Kroon, A.A., De Mey, J.G., Smits, P.A., de Leeuw, P.W. (2002): Nitric oxide and potassium channels are involved in brain natriuretic peptide induced vasodilatation in man. J Hypertens, 20, 493-439.
32. Wiley, K., Davenport, A. (2002): Comparison of vasodilators in human internal mammary artery. Ghrelin is a potent physiological antagonist of endothelin-1. Br J Pharmacol, 136, 1146-1152.
33. Yasue, H., Yoshimura, M. (1996): Natriuretic peptides in the treatment of heart failure. J Card Fail, 2, S277-S285.